BPC-157 vs NA Semax Amidate
Extensively Studied vs Well Studied
compatible Different mechanisms with complementary neuroprotective benefits.
Molecular Data
BPC-157 NA Semax Amidate
Weight 1,419.53 Da 1,007.16 Da
Half-life <30 minutes 2-10 hours
Chain 15 amino acids 7 amino acids
Type Pentadecapeptide Modified ACTH analog
Key Benefits
BPC-157
01 Accelerated tendon, ligament, muscle, and bone healing
02 Localized tissue repair with direct targeting
03 Superior bioavailability
04 Anti-inflammatory effects
05 Angiogenesis promotion
06 Gastric and intestinal protection
NA Semax Amidate
01 Direct brain access via olfactory nerves
02 Rapid onset (15-30 minutes)
03 Proven cognitive efficacy
04 Extended half-life vs standard Semax
05 Enhanced BDNF upregulation
Dosing Protocols
BPC-157
250-500mcg / Once or twice daily
Tendon/Joint healing 250-500 mcg 1-2x daily
Serious injury 500-1000 mcg 2x daily
General healing 250-500 mcg 1-2x daily
Maintenance 250 mcg 1x daily
NA Semax Amidate
600-1200mcg per administration / 1-2x daily for 10-30 days
Research protocol 200mcg 1x daily
Neuroprotection study 400mcg 1x daily
Side Effects
BPC-157
Mild injection site redness
Injection site irritation
Possible mild digestive adjustment (oral)
NA Semax Amidate
Mild nasal irritation (intranasal)
Slight headache initially
Contraindications
Active cancer (due to angiogenic effects)
Pregnancy or breastfeeding
Blood thinners (consult doctor due to angiogenesis)
WADA prohibited for competitive athletes
Not recommended during pregnancy
Active nasal congestion or sinus infection
Individuals on neurotransmitter-affecting medications without consultation
Research Evidence
BPC-157 NA Semax Amidate
Status Extensively Studied Well Studied
References 6 studies 4 studies
Latest January 2025 —
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.